Latest Research Reports

Report: Indonesian pharmaceutical market to be worth $10.11bn by 2021

Indonesia’s pharmaceutical market is projected to reach $10.11bn by 2021, according to a report by...

Report: Indonesian pharmaceutical market to be worth $10.11bn by 2021

Report: Alzheimer’s market set to achieve double-digit growth by 2026

The global Alzheimer’s disease (AD) market is expected to increase from $2.9bn in 2016 to $14.8bn, rising at a compound annual growth rate (CAGR) of 17.5%, according to a report by...

Report: Alzheimer’s market set to achieve double-digit growth by 2026

Report: Russian pharmaceutical market projected to grow to $36.61bn by 2021

Russia’s pharmaceutical market is expected to reach $36.61bn in value by 2021, according to a report by...

Report: Russian pharmaceutical market projected to grow to $36.61bn by 2021

Belimumab: The frontrunner in Lupus clinical trials

Belimumab: The frontrunner in Lupus clinical trials

Report: Global migraine market forecast to reach $8.7bn by 2026

Report: Global migraine market forecast to reach $8.7bn by 2026

Risk of sepsis is higher in an older population

Risk of sepsis is higher in an older population

Report: Multiple pipeline products to drive growth of healthcare-associated infections market

Report: Multiple pipeline products to drive growth of healthcare-associated infections market

The US and the UK see a high percentage of CDT+ CDI cases

The US and the UK see a high percentage of CDT+ CDI cases

Report: Sepsis and septic shock treatment to be $5.9bn market by 2026

The market for sepsis and septic shock across the seven major pharmaceutical markets of the US, France, Germany, Italy, Spain, the UK, and Japan is expected to reach $5.9bn by 2026, according to...

Report: Sepsis and septic shock treatment to be $5.9bn market by 2026

Emerging rivals in CAR-T cell therapies

Emerging rivals in CAR-T cell therapies

Japan leads in preventing CDI recurrences

Japan leads in preventing CDI recurrences

The quest for efficient and cost-effective R&D remains a challenge

The quest for efficient and cost-effective R&D remains a challenge

AEDs targeting rare epilepsy syndromes set to shoot to top of the market

AEDs targeting rare epilepsy syndromes set to shoot to top of the market

Novartis leads Japanese clinical trials

Novartis leads Japanese clinical trials

Report: Global HER2-positive breast cancer market set to reach $9.89bn by 2025

The human epidermal growth factor receptor type 2 (HER2)-positive breast cancer market is expected to face competition from the launch of biosimilars, according to a report by...

Report: Global HER2-positive breast cancer market set to reach $9.89bn by 2025

Top sponsors for 2007-2016 stem cell therapy clinical trials

Top sponsors for 2007-2016 stem cell therapy clinical trials

Nanobodies leading the way for biotech R&D deal

Nanobodies leading the way for biotech R&D deal

Report: Clostridium difficile infections market to reach $1.7bn by 2026

The global clostridium difficile infections (CDIs) market is expected to witness a compound annual growth rate (CAGR) of 10.2%, increasing from $630m in 2016 to $1.7bn by 2026, according to...

Report: Clostridium difficile infections market to reach $1.7bn by 2026

Early detection of invasive breast cancer substandard in urban China

Early detection of invasive breast cancer substandard in urban China

Anti-diabetic treatments with non-glycemic benefits: driver of growth

Anti-diabetic treatments with non-glycemic benefits: driver of growth

US faces high, growing burden of CDI

US faces high, growing burden of CDI